Life science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an ...

The U.S. Food and Drug Administration (FDA) has issued its recommendations to vaccine makers on which virus strains to select when manufacturing influenza (flu) vaccines for the 2025-2026 U.S. flu ...

The Public Health Agency of Canada said Wednesday it's purchased 500,000 doses of a human vaccine to protect against avian ...

Canada has announced a deal to secure 500K doses of GSK’s (NYSE:GSK) avian influenza vaccine for humans as the country steps up efforts to protect at-risk individuals and bolster its federal ...

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...

For the first time, the U.S. Department of Agriculture has confirmed the presence of H5N1 avian influenza in rats, raising fresh concerns about the virus’s ability to spread among mammals. The ...

Feb 19 (Reuters) - The Government of Canada has secured an initial supply of 500,000 doses of GSK's (GSK.L), opens new tab bird flu vaccine to protect individuals most at risk of being exposed to ...

Discover GSK's impressive stock surge, boosted by strong earnings, a share buyback program, and a focus on specialty medicines.

Good morning, everyone, and welcome to another working week. We hope the weekend respite was somehow refreshing and invigorating. After all, that oh-so familiar routine of phone calls, online ...